Minimal Clinically Important Improvement (MCII) of RAPID3 (ROUTINE ASSESSMENT OF PATIENT INDEX DATA 3), an INDEX of ONLY Patient Self-Report Scores in Rheumatoid Arthritis (RA): Similar Performance to DAS28 and CDAI

被引:0
|
作者
Ward, Michael [1 ]
Castrejon, Isabel [2 ]
Bergman, Martin J. [3 ]
Guthrie, Lori C. [1 ]
Alba, Maria I. [1 ]
Pincus, Theodore [2 ]
机构
[1] NIAMS, NIH, Bethesda, MD USA
[2] Rush Univ, Med Ctr, Rheumatol, Chicago, IL 60612 USA
[3] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1351
引用
收藏
页数:2
相关论文
共 50 条
  • [21] An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures
    Pincus, T.
    Bergman, M. J.
    Yazici, Y.
    Hines, P.
    Raghupathi, K.
    Maclean, R.
    RHEUMATOLOGY, 2008, 47 (03) : 345 - 349
  • [22] Correlation of RAPID3 (Routine Assessment of Patients Index Data 3), DAS28 (Disease Activity Score 28) and CDAI (Clinical Disease Activity Index) in Disease Activity and Effects of Education Level and Co-Morbid Diseases on this Assessment in RA
    Sahin, Kubilay
    Karaaslan, Yasar
    Ozbalkan, Zeynep
    Omma, Ahmet
    Yesil, Nesibe
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S37 - S37
  • [23] Performance of the Patient Reported Outcomes Measurement Information System 29-item Profile in Comparison to the Clinical Disease Activity Index (CDAI) and Routine Assessment of Patient Index Data 3 (RAPID3) in an Australian Rheumatoid Arthritis Cohort
    Gibson, Kathryn
    Gerogevsky, Dana
    Huang, Frank
    Fang, Ray
    Descallar, Joseph
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [24] UPADACITINIB VERSUS ADALIMUMAB ON ROUTINE ASSESSMENT OF PATIENT INDEX DATA 3 (RAPID3) IN PATIENTS WITH PSORIATIC ARTHRITIS
    Coates, L.
    Kavanaugh, A.
    Mcdearmon-Blondell, E.
    Mandelin, A.
    Gao, T.
    Tillett, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 843 - 844
  • [25] ROUTINE ASSESSMENT OF PATIENT INDEX DATA 3 (RAPID3) IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH LONG-TERM UPADACITINIB THERAPY
    Bergman, M.
    Buch, M. H.
    Tanaka, Y.
    Citera, G.
    Bahlas, S.
    Wong, E.
    Song, Y.
    Tundia, N.
    Suboticki, J.
    Strand, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 579 - 579
  • [26] Upadacitinib versus Adalimumab on Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Psoriatic Arthritis
    Coates, Laura
    Kavanaugh, Arthur
    McDearmon-Blondell, Erin
    Mandelin, Arthur
    Gao, Tianming
    Tillett, William
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 362 - 364
  • [27] RAPID3, An Index of Only 3 Patient Self-report Core Data Set Measures, but not ESR, Recognizes Incomplete Responses to Methotrexate in Usual Care of Patients with Rheumatoid Arthritis
    Pincus, Theodore
    BULLETIN OF THE HOSPITAL FOR JOINT DISEASES, 2013, 71 (02): : 117 - 120
  • [28] Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy
    Bergman, Martin
    Buch, Maya
    Tanaka, Yoshiya
    Citera, Gustavo
    Bahlas, Sami
    Wong, Ernest
    Song, Yanna
    Tundia, Namita
    Suboticki, Jessica
    Strand, Vibeke
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2547 - 2549
  • [29] Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice
    Boone, Niels W.
    Sepriano, Alexandre
    Van der Kuy, Paul-Hugo
    Janknegt, Rob
    Peeters, Ralph
    Landewe, Robert B. M.
    RMD OPEN, 2019, 5 (02):
  • [30] Routine Assessment of Patient Index Data-3 (RAPID3), a Patient-Reported Index to Guide a Treat-to-Target Strategy for Rheumatoid Arthritis in Usual Care
    Bergman, Martin J.
    Pincus, Theodore
    Castrejon, Isabel
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S124 - S124